AMP Capital Investors Ltd lifted its position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 2.4% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 376,449 shares of the pharmacy operator’s stock after acquiring an additional 8,684 shares during the quarter. AMP Capital Investors Ltd’s holdings in Walgreens Boots Alliance were worth $29,070,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Franklin Resources Inc. increased its holdings in Walgreens Boots Alliance by 24.7% during the 2nd quarter. Franklin Resources Inc. now owns 18,502,701 shares of the pharmacy operator’s stock worth $1,448,939,000 after purchasing an additional 3,662,302 shares in the last quarter. Arrowstreet Capital Limited Partnership increased its holdings in Walgreens Boots Alliance by 471.4% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 3,295,583 shares of the pharmacy operator’s stock worth $258,077,000 after purchasing an additional 2,718,800 shares in the last quarter. Vanguard Group Inc. boosted its stake in shares of Walgreens Boots Alliance by 2.8% in the 2nd quarter. Vanguard Group Inc. now owns 69,985,653 shares of the pharmacy operator’s stock worth $5,480,577,000 after buying an additional 1,926,108 shares during the last quarter. Glenview Capital Management LLC purchased a new position in shares of Walgreens Boots Alliance in the 2nd quarter worth approximately $136,875,000. Finally, Harding Loevner LP boosted its stake in shares of Walgreens Boots Alliance by 85.3% in the 3rd quarter. Harding Loevner LP now owns 2,844,207 shares of the pharmacy operator’s stock worth $115,725,000 after buying an additional 1,309,179 shares during the last quarter. 61.20% of the stock is currently owned by hedge funds and other institutional investors.
A number of brokerages have issued reports on WBA. Morgan Stanley cut shares of Walgreens Boots Alliance from an “overweight” rating to an “equal weight” rating and lowered their target price for the company from $95.00 to $85.00 in a report on Friday, October 6th. BidaskClub raised shares of Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a report on Friday, November 10th. Vetr raised shares of Walgreens Boots Alliance from a “buy” rating to a “strong-buy” rating in a report on Tuesday, December 12th. Robert W. Baird reaffirmed an “outperform” rating and issued a $80.00 price target (down previously from $90.00) on shares of Walgreens Boots Alliance in a report on Thursday, October 19th. They noted that the move was a valuation call. Finally, Citigroup decreased their price target on shares of Walgreens Boots Alliance from $95.00 to $81.00 and set a “buy” rating on the stock in a report on Thursday, November 2nd. Nine research analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $86.20.
Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share for the quarter, beating analysts’ consensus estimates of $1.27 by $0.01. Walgreens Boots Alliance had a net margin of 3.19% and a return on equity of 19.15%. The company had revenue of $30.74 billion for the quarter, compared to analysts’ expectations of $30.39 billion. During the same quarter in the previous year, the company earned $1.10 EPS. Walgreens Boots Alliance’s revenue for the quarter was up 7.9% on a year-over-year basis. analysts expect that Walgreens Boots Alliance Inc will post 5.7 EPS for the current fiscal year.
Walgreens Boots Alliance announced that its board has initiated a stock repurchase plan on Wednesday, October 25th that authorizes the company to repurchase $1.00 billion in shares. This repurchase authorization authorizes the pharmacy operator to repurchase shares of its stock through open market purchases. Shares repurchase plans are often an indication that the company’s board of directors believes its shares are undervalued.
In other news, Director John Anthony Lederer purchased 20,000 shares of the business’s stock in a transaction that occurred on Thursday, October 26th. The shares were bought at an average cost of $67.00 per share, for a total transaction of $1,340,000.00. Following the acquisition, the director now owns 50,000 shares of the company’s stock, valued at approximately $3,350,000. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director William C. Foote sold 2,736 shares of the company’s stock in a transaction dated Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total transaction of $184,324.32. Following the transaction, the director now owns 16,415 shares in the company, valued at $1,105,878.55. The disclosure for this sale can be found here. 14.80% of the stock is currently owned by insiders.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.